Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
769.760.06%
QQQ
717.970.14%
BTC/USD
79655.981.9934%
DIA
532.680.26%
GLD
406.400.09%
TLT
82.250.05%

Treace Medical Concepts Inc

TMCINASDAQ
Trade with Public
Trade with Public
$4.81
-0.07-1.43%
At close: Sep 4, 5:00 PM EST
$4.81
N/A
After Hours: 4:00 PM EST
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareOptionsStock Report

Treace Medical Concepts Analyst Price Targets

Wall Street analyst price targets and consensus rating for Treace Medical Concepts (TMCI).

Price Target Range — 11 Quarters

Analyst Consensus — 6 Analysts

1Buy
4Hold
1Sell
Consensus RatingEqual-Weight# Analysts6Avg. Consensus PT$8Upside to Avg. PT+73.8%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →
DateFirmAnalystActionRating ChangePrice Target
Aug 10, 2026Truist SecuritiesRichard NewitterPT RaiseHold$4→$5
Jul 16, 2026Truist SecuritiesRichard NewitterPT RaiseHold$2→$4
More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $5

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $4 to $5.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Raises Price Target to $4

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and raises the price target from $2 to $4.
Benzinga Newsdesk

PRO
Lake Street Maintains Buy on Treace Medical Concepts, Lowers Price Target to $7

Lake Street analyst Ben Haynor maintains Treace Medical Concepts (NASDAQ:TMCI) with a Buy and lowers the price target from $7.5 to $7.
Benzinga Newsdesk

The Analyst Verdict: Treace Medical Concepts In The Eyes Of 6 Experts

Benzinga Insights

PRO
Stifel Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

Stifel analyst Rick Wise maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $5 to $3.
Benzinga Newsdesk

PRO
Truist Securities Maintains Hold on Treace Medical Concepts, Lowers Price Target to $3

Truist Securities analyst Richard Newitter maintains Treace Medical Concepts (NASDAQ:TMCI) with a Hold and lowers the price target from $4 to $3.
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Market data provided by Benzinga APIs

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved